基于 CT 的心肌表征 (CTMyoC) (CTMyoC)
基于 CT 的心肌表征
分别采用晚期钆增强 (LGE) 技术和心脏磁共振中细胞外体积分数 (ECV) 的定量评估,根据心肌疤痕和细胞外基质重塑来识别心肌纤维化,已被证明在心肌纤维化的诊断中至关重要。不同心肌病的诊断并作为主要心血管不良事件的预测指标[1-14]。
因此,CMR 代表了临床实践中心肌组织无创表征的黄金标准。
然而,尽管 CMR 具有无可争议的临床作用,但它也有许多局限性:1)它不能评估冠状动脉; 2) 对于使用心脏装置的患者是禁忌的,并且在有条件装置的情况下,它们还可能由于人工制品而显着损害 LGE 可评估性 [19]); 2)可用性有限且耗时,因此由于患者依从性差而难以在紧急情况下进行; 3)对于患有幽闭恐惧症的患者来说这是不可行的。 心脏计算机断层扫描 (cCT) 是非侵入性研究冠状动脉的首选图像,无法使用 CMR 进行评估。 此外,最近的技术进步不断增加了评估心脏瓣膜和纤维化的临床适应症,减少了 CMR 的采集时间(几分钟与 1 小时)、辐射暴露和成本。
在表征心肌疤痕和细胞外体积分数方面,cCT 已成为 CMR 的可能替代方案,其优点是单次评估冠状动脉和心肌组织重塑(疤痕、弥漫性纤维化、收缩性......)。包括我们小组的一些研究在内,已经证明了 cCT 心肌组织表征在不同临床环境中的临床实用性,例如心肌梗塞 [20, 21]、心肌炎 [22]、肥厚型心肌病 (HCM) [23]、心力衰竭 [ 24]、室性心动过速[25]和结节病[26]。 尽管结果很有趣,但所有这些先前的研究都仅限于高度选择性和小样本量。 此外,任何具有长期随访的大型研究都可以在 cCT 中的组织特征(心肌疤痕和 ECV)方面进行,也可以与多参数方法(心室形态功能、收缩性应变、瓣膜钙化、几何形状、冠状动脉粥样硬化、心肌灌注、心肌应变和纹理),但没有关于其预后影响的数据。 该研究的目的是评估 cCT 在组织特征(心肌疤痕和 ECV)方面的潜力,以及与大量临床候选心脏 CT 患者的其他 CT 成像生物标志物相关联的潜力。
研究概览
地位
条件
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Anna Palmisano
- 邮箱:palmisano.anna@hsr.it
研究联系人备份
- 姓名:Antonio Esposito
- 电话号码:02 2643 6102
- 邮箱:esposito.antonio@hsr.it
学习地点
-
-
-
Milan、意大利
- 招聘中
- IRCCS San Raffaele
-
接触:
- Antonio Esposito
- 电话号码:02 2643 6102
- 邮箱:esposito.antonio@hsr.it
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
这是一项具有回顾性和前瞻性的单中心观察性研究。
患者将从我们机构的放射科(IRCCS Ospedale San Raffaele,米兰,意大利)招募。 将获得书面知情同意书。
描述
纳入标准:
a) 年龄≥18岁; b) 无 cCT 禁忌症; c) 签署知情同意书; d) 因以下原因而进行 cCT 的临床指征:稳定型心绞痛、心力衰竭、房性/室性心律失常、需要“三重排除”扫描的急性胸痛、瓣膜修复/替代计划、结构性和浸润性心肌病、新的发病时心电图改变,肌钙蛋白增加。
排除标准:
(a) 年龄 < 18 岁; (b) 怀孕和/或哺乳; (c) 服用碘造影剂的禁忌症或肾功能受损(eGFR ≤ 30 mL/min); (d) 无法维持短暂屏气(5 秒)。
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
回顾性队列
该研究的回顾性研究将包括 200 名符合纳入标准的患者,这些患者从 2013 年 1 月到批准修正案之日接受了心脏 CT 检查。
(选择 2013 年作为检索 CT 和临床日期的起始年,以便对每个患者进行至少 5 年的随访)。
|
|
未来队列
该研究的前瞻性部分将包括 2000 名连续符合纳入标准的患者,这些患者在批准之日起 7 年内接受心脏 CT 检查。
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
综合结果
大体时间:60个月
|
因心力衰竭 (HHF) 或死亡(全因死亡率)首次住院。
|
60个月
|
合作者和调查者
出版物和有用的链接
一般刊物
- Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011 Feb 22;57(8):891-903. doi: 10.1016/j.jacc.2010.11.013.
- Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2014 Mar;7(2):250-258. doi: 10.1161/CIRCIMAGING.113.001144. Epub 2013 Dec 20.
- Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, He Y. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. JACC Cardiovasc Imaging. 2016 Dec;9(12):1392-1402. doi: 10.1016/j.jcmg.2016.02.031. Epub 2016 Jul 20.
- Dickfeld T, Tian J, Ahmad G, Jimenez A, Turgeman A, Kuk R, Peters M, Saliaris A, Saba M, Shorofsky S, Jeudy J. MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol. 2011 Apr;4(2):172-84. doi: 10.1161/CIRCEP.110.958744. Epub 2011 Jan 26.
- Mavrogeni S, Petrou E, Kolovou G, Theodorakis G, Iliodromitis E. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):518-25. doi: 10.1093/ehjci/jes302. Epub 2013 Jan 16.
- Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson. 2016 Nov 30;18(1):89. doi: 10.1186/s12968-016-0308-4.
- Bulluck H, Hammond-Haley M, Fontana M, Knight DS, Sirker A, Herrey AS, Manisty C, Kellman P, Moon JC, Hausenloy DJ. Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping. J Cardiovasc Magn Reson. 2017 Aug 1;19(1):57. doi: 10.1186/s12968-017-0370-6.
- Youn JC, Hong YJ, Lee HJ, Han K, Shim CY, Hong GR, Suh YJ, Hur J, Kim YJ, Choi BW, Kang SM. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol. 2017 Sep;27(9):3924-3933. doi: 10.1007/s00330-017-4817-9. Epub 2017 Apr 24.
- Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013 Oct;6(10):1048-1058. doi: 10.1016/j.jcmg.2013.03.008. Epub 2013 Sep 4.
- Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, Gebker R, Doltra A, Kelle S, Khan S, Rogers T, Arroyo Ucar E, Cummins C, Carr-White G, Nagel E, Puntmann VO. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging. 2015 Dec;8(12):e003285. doi: 10.1161/CIRCIMAGING.115.003285.
- Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E. T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis. Radiology. 2017 Oct;285(1):63-72. doi: 10.1148/radiol.2017162732. Epub 2017 Apr 27.
- Martinez-Naharro A, Kotecha T, Norrington K, Boldrini M, Rezk T, Quarta C, Treibel TA, Whelan CJ, Knight DS, Kellman P, Ruberg FL, Gillmore JD, Moon JC, Hawkins PN, Fontana M. Native T1 and Extracellular Volume in Transthyretin Amyloidosis. JACC Cardiovasc Imaging. 2019 May;12(5):810-819. doi: 10.1016/j.jcmg.2018.02.006. Epub 2018 Mar 14.
- Karur GR, Robison S, Iwanochko RM, Morel CF, Crean AM, Thavendiranathan P, Nguyen ET, Mathur S, Wasim S, Hanneman K. Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy. Radiology. 2018 Aug;288(2):398-406. doi: 10.1148/radiol.2018172613. Epub 2018 Apr 24.
- Neilan TG, Coelho-Filho OR, Shah RV, Feng JH, Pena-Herrera D, Mandry D, Pierre-Mongeon F, Heydari B, Francis SA, Moslehi J, Kwong RY, Jerosch-Herold M. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol. 2013 Mar 1;111(5):717-22. doi: 10.1016/j.amjcard.2012.11.022. Epub 2012 Dec 8.
- Treibel TA, Fridman Y, Bering P, Sayeed A, Maanja M, Frojdh F, Niklasson L, Olausson E, Wong TC, Kellman P, Miller CA, Moon JC, Ugander M, Schelbert EB. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1. JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):44-54. doi: 10.1016/j.jcmg.2019.03.017. Epub 2019 May 15.
- Barone-Rochette G, Pierard S, De Meester de Ravenstein C, Seldrum S, Melchior J, Maes F, Pouleur AC, Vancraeynest D, Pasquet A, Vanoverschelde JL, Gerber BL. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol. 2014 Jul 15;64(2):144-54. doi: 10.1016/j.jacc.2014.02.612.
- Chin CWL, Everett RJ, Kwiecinski J, Vesey AT, Yeung E, Esson G, Jenkins W, Koo M, Mirsadraee S, White AC, Japp AG, Prasad SK, Semple S, Newby DE, Dweck MR. Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis. JACC Cardiovasc Imaging. 2017 Nov;10(11):1320-1333. doi: 10.1016/j.jcmg.2016.10.007. Epub 2016 Dec 21.
- Chaikriangkrai K, Lopez-Mattei JC, Lawrie G, Ibrahim H, Quinones MA, Zoghbi W, Little SH, Shah DJ. Prognostic value of delayed enhancement cardiac magnetic resonance imaging in mitral valve repair. Ann Thorac Surg. 2014 Nov;98(5):1557-63. doi: 10.1016/j.athoracsur.2014.06.049. Epub 2014 Sep 18.
- Steen H, Madadi-Schroeder M, Lehrke S, Lossnitzer D, Giannitsis E, Katus HA. Staged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndrome. J Cardiovasc Magn Reson. 2010 Sep 14;12(1):51. doi: 10.1186/1532-429X-12-51.
- Tanabe Y, Kido T, Kurata A, Kouchi T, Fukuyama N, Yokoi T, Uetani T, Yamashita N, Miyagawa M, Mochizuki T. Late iodine enhancement computed tomography with image subtraction for assessment of myocardial infarction. Eur Radiol. 2018 Mar;28(3):1285-1292. doi: 10.1007/s00330-017-5048-9. Epub 2017 Sep 19.
- Rodriguez-Granillo GA. Delayed enhancement cardiac computed tomography for the assessment of myocardial infarction: from bench to bedside. Cardiovasc Diagn Ther. 2017 Apr;7(2):159-170. doi: 10.21037/cdt.2017.03.16.
- Bouleti C, Baudry G, Iung B, Arangalage D, Abtan J, Ducrocq G, Steg PG, Vahanian A, Henry-Feugeas MC, Pasi N, Chillon S, Pitocco F, Laissy JP, Ou P. Usefulness of Late Iodine Enhancement on Spectral CT in Acute Myocarditis. JACC Cardiovasc Imaging. 2017 Jul;10(7):826-827. doi: 10.1016/j.jcmg.2016.09.013. Epub 2016 Dec 21. No abstract available.
- Zhao L, Ma X, Delano MC, Jiang T, Zhang C, Liu Y, Zhang Z. Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography. Eur Radiol. 2013 Apr;23(4):1034-43. doi: 10.1007/s00330-012-2674-0. Epub 2012 Oct 14.
- Ohta Y, Kitao S, Yunaga H, Fujii S, Mukai N, Yamamoto K, Ogawa T. Myocardial Delayed Enhancement CT for the Evaluation of Heart Failure: Comparison to MRI. Radiology. 2018 Sep;288(3):682-691. doi: 10.1148/radiol.2018172523. Epub 2018 Jul 10.
- Esposito A, Palmisano A, Antunes S, Maccabelli G, Colantoni C, Rancoita PMV, Baratto F, Di Serio C, Rizzo G, De Cobelli F, Della Bella P, Del Maschio A. Cardiac CT With Delayed Enhancement in the Characterization of Ventricular Tachycardia Structural Substrate: Relationship Between CT-Segmented Scar and Electro-Anatomic Mapping. JACC Cardiovasc Imaging. 2016 Jul;9(7):822-832. doi: 10.1016/j.jcmg.2015.10.024. Epub 2016 Feb 17.
- Aikawa T, Oyama-Manabe N, Naya M, Ohira H, Sugimoto A, Tsujino I, Obara M, Manabe O, Kudo K, Tsutsui H, Tamaki N. Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study. Eur Radiol. 2017 Oct;27(10):4054-4063. doi: 10.1007/s00330-017-4824-x. Epub 2017 Apr 5.
- Nacif MS, Kawel N, Lee JJ, Chen X, Yao J, Zavodni A, Sibley CT, Lima JA, Liu S, Bluemke DA. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. Radiology. 2012 Sep;264(3):876-83. doi: 10.1148/radiol.12112458. Epub 2012 Jul 6.
- Marwan M, Achenbach S, Korosoglou G, Schmermund A, Schneider S, Bruder O, Hausleiter J, Schroeder S, Barth S, Kerber S, Leber A, Moshage W, Senges J. German cardiac CT registry: indications, procedural data and clinical consequences in 7061 patients undergoing cardiac computed tomography. Int J Cardiovasc Imaging. 2018 May;34(5):807-819. doi: 10.1007/s10554-017-1282-0. Epub 2017 Dec 1.
- Knuuti J, Bengel F, Bax JJ, Kaufmann PA, Le Guludec D, Perrone Filardi P, Marcassa C, Ajmone Marsan N, Achenbach S, Kitsiou A, Flotats A, Eeckhout E, Minn H, Hesse B. Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. Eur Heart J. 2014 Mar;35(10):633-8. doi: 10.1093/eurheartj/eht512. Epub 2013 Dec 29. No abstract available.
- Esposito A, Palmisano A, Barbera M, Vignale D, Benedetti G, Spoladore R, Ancona MB, Giannini F, Oppizzi M, Del Maschio A, De Cobelli F. Cardiac Computed Tomography in Troponin-Positive Chest Pain: Sometimes the Answer Lies in the Late Iodine Enhancement or Extracellular Volume Fraction Map. JACC Cardiovasc Imaging. 2019 Apr;12(4):745-748. doi: 10.1016/j.jcmg.2018.08.013. Epub 2018 Oct 17. No abstract available.
- Vignale D, Palmisano A, Gnasso C, Margonato D, Romagnolo D, Barbieri S, Ingallina G, Stella S, Ancona MB, Montorfano M, Maisano F, Agricola E, Esposito A. Extracellular volume fraction (ECV) derived from pre-operative computed tomography predicts prognosis in patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J Cardiovasc Imaging. 2023 Jun 21;24(7):887-896. doi: 10.1093/ehjci/jead040.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.